Ontology highlight
ABSTRACT:
SUBMITTER: Zhang Y
PROVIDER: S-EPMC6769604 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
Zhang Yingxuan Y Fang Zheyan Z Li Ruizhen R Huang Xiaotian X Liu Qiong Q
Cancers 20190906 9
Cancer vaccines have been extensively studied in recent years and have contributed to exceptional achievements in cancer treatment. They are some of the most newly developed vaccines, although only two are currently approved for use, Provenge and Talimogene laherparepvec (T-VEC). Despite the approval of these two vaccines, most vaccines have been terminated at the clinical trial stage, which indicates that although they are effective in theory, concerns still exist, including low antigenicity of ...[more]